Sang-A Frontec Co.,Ltd.

KOSDAQ:A089980 Rapport sur les actions

Capitalisation boursière : ₩281.4b

Sang-A FrontecLtd Croissance future

Future contrôle des critères 4/6

Sang-A FrontecLtd devrait augmenter ses bénéfices et son chiffre d'affaires de 37.1% et de 17.5% par an respectivement. Le BPA devrait croître de de 28.1% par an. Le rendement des capitaux propres devrait être 6.3% dans 3 ans.

Informations clés

37.1%

Taux de croissance des bénéfices

28.1%

Taux de croissance du BPA

Electronic croissance des bénéfices34.9%
Taux de croissance des recettes17.5%
Rendement futur des capitaux propres6.3%
Couverture par les analystes

Low

Dernière mise à jour17 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Is It Too Late To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

Nov 15
Is It Too Late To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

Is Sang-A FrontecLtd (KOSDAQ:089980) Using Too Much Debt?

Aug 15
Is Sang-A FrontecLtd (KOSDAQ:089980) Using Too Much Debt?

With A 25% Price Drop For Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) You'll Still Get What You Pay For

Jul 30
With A 25% Price Drop For Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) You'll Still Get What You Pay For

Investors Could Be Concerned With Sang-A FrontecLtd's (KOSDAQ:089980) Returns On Capital

Jun 08
Investors Could Be Concerned With Sang-A FrontecLtd's (KOSDAQ:089980) Returns On Capital

Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) 26% Share Price Surge Not Quite Adding Up

May 07
Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) 26% Share Price Surge Not Quite Adding Up

Is It Time To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

May 02
Is It Time To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

We Think Sang-A FrontecLtd (KOSDAQ:089980) Is Taking Some Risk With Its Debt

Apr 12
We Think Sang-A FrontecLtd (KOSDAQ:089980) Is Taking Some Risk With Its Debt

Returns On Capital Signal Tricky Times Ahead For Sang-A FrontecLtd (KOSDAQ:089980)

Apr 13
Returns On Capital Signal Tricky Times Ahead For Sang-A FrontecLtd (KOSDAQ:089980)

Estimating The Intrinsic Value Of Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)

Mar 02
Estimating The Intrinsic Value Of Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)

These 4 Measures Indicate That Sang-A FrontecLtd (KOSDAQ:089980) Is Using Debt Extensively

Feb 14
These 4 Measures Indicate That Sang-A FrontecLtd (KOSDAQ:089980) Is Using Debt Extensively

Is Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) Potentially Undervalued?

Jan 24
Is Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) Potentially Undervalued?

Shareholders Of Sang-A FrontecLtd (KOSDAQ:089980) Must Be Happy With Their 286% Total Return

Jan 05
Shareholders Of Sang-A FrontecLtd (KOSDAQ:089980) Must Be Happy With Their 286% Total Return

What Type Of Shareholders Make Up Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) Share Registry?

Dec 21
What Type Of Shareholders Make Up Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) Share Registry?

Should We Be Excited About The Trends Of Returns At Sang-A FrontecLtd (KOSDAQ:089980)?

Dec 03
Should We Be Excited About The Trends Of Returns At Sang-A FrontecLtd (KOSDAQ:089980)?

Prévisions de croissance des bénéfices et des revenus

KOSDAQ:A089980 - Estimations futures des analystes et données financières antérieures (KRW Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026247,60010,300-19,0006,3001
12/31/2025191,6003,200-8,10011,5001
12/31/2024182,9003,250-21,4003,4002
6/30/2024176,4217,656-5,72733,694N/A
3/31/2024180,48910,997-11,04916,242N/A
12/31/2023183,59911,994-15728,675N/A
9/30/2023187,6552,5996,13935,047N/A
6/30/2023189,9425,873-1,76619,587N/A
3/31/2023186,9747,829-10,32717,439N/A
12/31/2022181,1567,426-12,81215,607N/A
9/30/2022180,3849,911-19,62612,847N/A
6/30/2022178,99810,096-19,55614,410N/A
3/31/2022179,2348,988-11,51620,042N/A
12/31/2021178,4819,299-19,15320,857N/A
9/30/2021177,4576,214-27,77911,924N/A
6/30/2021172,4492,772-25,4897,515N/A
3/31/2021159,4312,248-9,17617,664N/A
12/31/2020153,3472,320-2,20412,455N/A
9/30/2020147,6574,102-2,48310,870N/A
6/30/2020151,3796,7014,96316,621N/A
3/31/2020169,4239,471-10,989134N/A
12/31/2019186,17112,454-6,7703,513N/A
9/30/2019199,50717,3801,8166,285N/A
6/30/2019202,03917,597-1,5324,030N/A
3/31/2019193,00915,508-1897,607N/A
12/31/2018182,07412,064-3,3977,468N/A
9/30/2018162,3007,398-4,67511,845N/A
6/30/2018155,2696,323-2,01014,428N/A
3/31/2018155,9478,391N/A20,875N/A
12/31/2017153,2367,467N/A25,206N/A
9/30/2017156,37010,604N/A26,466N/A
6/30/2017151,7968,908N/A22,206N/A
3/31/2017155,6016,367N/A14,905N/A
12/31/2016156,2955,467N/A2,831N/A
9/30/2016156,2102,276N/A2,211N/A
6/30/2016155,7445,008N/A5,469N/A
3/31/2016146,0096,552N/A3,341N/A
12/31/2015143,7407,858N/A9,152N/A
9/30/2015140,4866,813N/A8,574N/A
6/30/2015136,9634,968N/A8,418N/A
3/31/2015134,0783,448N/A11,176N/A
12/31/2014128,3834,048N/A9,632N/A
9/30/2014130,2087,120N/A7,711N/A
6/30/2014126,3327,195N/A7,430N/A
3/31/2014115,7397,517N/A12,185N/A
12/31/2013107,8126,979N/A13,548N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de A089980 ( 37.1% par an) est supérieure au taux d'épargne ( 2.7% ).

Bénéfices vs marché: Les bénéfices de A089980 ( 37.1% par an) devraient croître plus rapidement que le marché KR ( 28% par an).

Croissance élevée des bénéfices: Les bénéfices de A089980 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de A089980 ( 17.5% par an) devrait croître plus rapidement que le marché KR ( 9.4% par an).

Croissance élevée des revenus: Le chiffre d'affaires de A089980 ( 17.5% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de A089980 devrait être faible dans 3 ans ( 6.3 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y